Bio-Techne
TECH
#2211
Rank
HK$70.49 B
Marketcap
HK$450.56
Share price
5.19%
Change (1 day)
-11.33%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Bio-Techne (TECH) - Total debt

Total debt on the balance sheet as of December 2025 : HK$2.74 Billion

According to Bio-Techne's latest financial reports the company's total debt is HK$2.74 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Bio-Techne - Total debt on balance sheet (from 1999 to 2025)

Total debt by year

Year Total debt Change
2025-06-30HK$3.48 B6.4%
2024-06-30HK$3.27 B-8.11%
2023-06-30HK$3.56 B39.37%
2022-06-30HK$2.55 B-21.66%
2021-06-30HK$3.26 B-2.82%
2020-06-30HK$3.36 B-14.85%
2019-06-30HK$3.94 B48.33%
2018-06-30HK$2.66 B-0.86%
2017-06-30HK$2.68 B263.07%
2016-06-30HK$0.73 B23.81%
2015-06-30HK$0.59 B495.04%
2014-06-30HK$0.10 B
2006-06-30HK$0.10 B-8.17%
2005-06-30HK$0.11 B-8.15%
2004-06-30HK$0.12 B-7.19%
2003-06-30HK$0.13 B-5.37%
2002-06-30HK$0.14 B-4.68%
2001-06-30HK$0.14 B-4.1%
2000-06-30HK$0.15 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Thermo Fisher Scientific
TMO
HK$279.09 B 10,068.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
HK$150.03 B 5,366.31%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
HK$160.31 B 5,740.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
HK$131.85 B 4,703.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
HK$16.63 B 506.22%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Enzo Biochem
ENZB
HK$23.49 M-99.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
HK$10.91 B 297.64%๐Ÿ‡บ๐Ÿ‡ธ USA